CCG-led round will be used to drive rapid adoption of new digital platform that eliminates inaccuracy and bias in identification of people suffering from mental health disorders
Artificial intelligence (AI)-powered mental health screening pioneer Aiberry…
Health insurer Cigna added behavioral health provider ReKlame Health to its network in an effort to expand access for underserved communities, the companies announced Thursday.
New York City-based ReKlame Health is a virtual provider for…
What You Should Know:– ReKlame Health, a provider of culturally competent, affordable and empathetic behavioral healthcare for BIPOC communities, announced that it has joined Cigna as an in-network mental healthcare provider in New York,…
Continue Reading
Virtual reality company Neuromersiv has teamed up with Askham Village to trial its latest products which are designed for immersive and engaging neurorehabilitation with patients recovering from a stroke.Cambridge-based specialist rehabilitation provider Askham Village…
Continue Reading
Accelerator alumni, Mendelian, Cibiltech and Ibex, have secured funding through the third competition of the Artificial Intelligence in Health and Care Awards.The awards are run by the NHS AI Lab in partnership with the…
Continue Reading
Zocdoc, which provides quick access to a person’s local in-network provider, has teamed up with maternal healthcare startup Zaya Care to provide insurance-covered pregnancy and postpartum care for patients in New Jersey and New York,…
Continue Reading
What You Should Know:– Aiberry (pronounced “I” + “berry”), an AI-powered mental health screening pioneer today announced that it has secured $8M in seed funding led by Confluence Capital Group, Inc. (CCG) with participation…
Continue Reading
Zaya Care, a network of pregnancy and postpartum care that takes insurance, will leverage Zocdoc to broaden access to maternity services.WHY IT MATTERSNew parents can now find and book video as well as in-person…
Continue Reading
Adaptimmune and TCR2 Therapeutics, two clinical-stage biotechs that have recently cut staff to conserve capital, are coming together in a deal that aligns their cell therapy strategies. The business combination also extends the new…
Continue Reading
